Install
Ipsen is a global biopharmaceutical company focused on innovation and specialty care to improve the lives of patients around the world.
- 54articles · 365d
- 4+ day agolatest article
- Sep 16, 2025earliest in window
- 98%with images
- 256avg words
- Health & Wellness 31
- Medical 30
- Science & Technology 21
- Business & Industrial 14
- Economy, Business & Finance 14
- Finance & Business 14
- Health 14
- Science & Nature 10
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Why evidence matters: Seema Meloni on making data meaningful
4+ day, 4+ hour ago (338+ words) “In order to help all partners understand the value of a medicine, we provide the wrap-around support of data coming out of clinical trials.” Clinical trials answer specific questions in very structured settings and under controlled conditions. Seema Meloni’s team…...
From molecule to medicine: the process behind patient-ready treatments
1+ mon, 1+ week ago (330+ words) “We need to make sure that it’s scalable, safe, and reproducible—so that every patient gets the same medicine every time.” As a CMC lead focused on new asset development, Ian Fox works at the intersection of research and application…...
Testing the hypothesis: a focused pilot for AI in healthcare - Global
1+ mon, 4+ week ago (158+ words) Every scientific breakthrough begins with a question: can this medicine extend life, restore balance, or meaningfully change what is possible for patients? At Ipsen, we are bringing that same discipline to artificial intelligence, asking whether it can help our teams…...
Balancing benefit and risk: Nisha Vora on the science of pharmacovigilance
2+ mon, 3+ week ago (319+ words) “My job is to be a guardian of patient safety.”As Safety Science Director, she works across both early development and post-marketing, ensuring that risks are anticipated, analyzed, and managed so treatments can reach patients responsibly. That attention does not…...
Biopharma deals thrive on creativity, from structure through to execution
3+ mon, 6+ day ago (339+ words) Science has changed – the best deals evolve with it Many conventional deal structures weren’t built for this reality. They prioritize stability at signing: rigid frameworks based on assumptions that may not survive first contact with the data. Science is iterative…...
World Environment Day: Acting where it matters most
3+ mon, 1+ week ago (288+ words) By mobilizing the right partners across our value chain and engaging our employees to move forward together For a company like Ipsen, environmental impact doesn’t stop at the boundaries of its operations. In fact, that’s only a small part of…...
Choosing the hardest problems: why Ipsen focuses where unmet need is greatest
3+ mon, 1+ week ago (277+ words) By Christelle Huguet, EVP & Head of R&D, Ipsen In biopharmaceutical research, not all challenges are equal. Some of the most meaningful opportunities lie in areas defined by complex biology, limited evidence, and patients who have waited far too long…...
Why post approval evidence is redefining the future of patient care
3+ mon, 2+ week ago (158+ words) By Sandra Silvestri, for Ipsen.com The expanding role of RWE Clinical trials answer essential scientific questions, but by design, they can never fully capture the reality of people’s everyday lives—the diversity of experiences, the complexity of conditions, and…...
Our 2025 Sustainability Statement is Live: Here's What It Means for Ipsen
4+ mon, 2+ week ago (23+ words) Ipsen’s 2025 Sustainability Statement - the annual publication outlining Ipsen’s environmental, social and governance (ESG) commitments, progress and priorities - is now available...
Right medicine, right person: Jacintha Sivarajah on science with purpose
3+ mon, 4+ week ago (204+ words) “All medicines have side effects, but it’s just about trying to minimize the impact through providing the information patients and clinicians need or finding other ways to mitigate that impact.” — Jacintha Sivarajah With over 15 years of experience in the pharmaceutical…...